# Concurrent Chemo-radiotherapy With Intensity-Modulated Radiation Therapy (IMRT) for Limited Disease Small Cell Lung Cancer (LD-SCLC)

> **NCT01166191** · PHASE2 · COMPLETED · sponsor: **Maastricht Radiation Oncology** · enrollment: 60 (actual)

## Conditions studied

- Stage I-III Small Cell Lung Cancer

## Interventions

- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT01166191
- **Lead sponsor:** Maastricht Radiation Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01166191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01166191, "Concurrent Chemo-radiotherapy With Intensity-Modulated Radiation Therapy (IMRT) for Limited Disease Small Cell Lung Cancer (LD-SCLC)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01166191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*